A First-in-Human Study of SBP-9330 in Healthy Subjects

Clinical trial NCT04948827 · COMPLETED

Trial details

NCT number: NCT04948827
Sponsor: Camino Pharma, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2021-07-20
Primary completion: 2023-03-06
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.